The effects of resistance training on ApoB/ApoA-I ratio, Lp(a) and inflammatory markers in patients with type 2 diabetes

被引:50
作者
Kadoglou, Nikolaos P. E. [1 ,2 ]
Fotiadis, Grigorios [2 ]
Athanasiadou, Zoi [2 ]
Vitta, Ioulia [2 ]
Lampropoulos, Stylianos [3 ]
Vrabas, Ioannis S. [1 ]
机构
[1] Aristotle Univ Thessaloniki, Dept Phys Educ & Sports Sci, Ag Ioannis 62110, Serres, Greece
[2] Hippokrateion Hosp, Dept Internal Med 1, Thessaloniki, Greece
[3] Bodosakio Gen Hosp Ptolemaida, Dept Cardiol, Ptolemaida, Greece
关键词
Type; 2; diabetes; Resistance training; Exercise; Insulin resistance; Apolipoprotein A-I; Apolipoprotein B; Lp(a); hsCRP; CARDIOVASCULAR RISK-FACTORS; APOLIPOPROTEIN-A-I; EXERCISE; MELLITUS; LIPOPROTEIN(A); METAANALYSIS; INTERVENTION; ASSOCIATION; PREVENTION; BENEFITS;
D O I
10.1007/s12020-012-9650-y
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The purpose of this study was to investigate the effects of resistance training (RT) on novel cardiovascular risk factors in patients with type 2 diabetes mellitus (T2DM). We enrolled 52 overweight/obese, type 2 diabetic patients, with inadequate glycemic control (HbA1c > 6.5 %), but without overt diabetic vascular complications. Participants were randomly assigned into two equivalent groups (n = 26): (1) Resistance exercise group: subjects underwent a supervised RT program (3-times/week, 60 min/session, 2-3 sets of 8 machine-weight exercises, 60-80 % of one-repetition maximum). (2) Control group (CG): at study entrance, they received a structured exercise counseling to increase daily physical activity. Clinical parameters, cardiorespiratory capacity, glycemic and lipid profile, apolipoprotein A-I (ApoA-I), apolipoprotein B (ApoB), Lipoprotein(a) [Lp(a)], insulin resistance (HOMA-IR), high-sensitivity CRP (hsCRP), fibrinogen were measured before and after 3 months. RT significantly reduced glycemic indexes, insulin resistance and systolic blood pressure, compared to CG (p < 0.05). Moreover, exercise-treated patients conferred a remarkable downregulation in ApoB levels (from 135.92 +/- A 30.97 mg/dL to 85.9 +/- A 26.46 mg/dL, p < 0.001) as compared to CG (from 126.33 +/- A 36.59 mg/dL to 116.23 +/- A 27.52 mg/dL, p = 0.872) (p < 0.001). Similarly, ApoB/ApoA-I ratio was considerably decreased in REG rather than CG (-0.32 +/- A 0.09 vs 0.02 +/- A 0.01, p < 0.001). Notably, ApoA-I, Lp(a), hsCRP, fibrinogen, the rest of lipid parameters, body weight and exercise capacity remained unaltered in both groups (p > 0.05). Among variables, HOMA-IR reduction was found to be an independent predictor of changes in ApoB/ApoA-I ratio (R (2) = 0.406, p = 0.041) in REG. Long-term RT ameliorated glycemic control, insulin sensitivity and ApoB/ApoA-I ratio in individuals with T2DM. Although we did not observe significant benefits in the rest of cardiovascular risk factors, our results indicate a merely beneficial impact of RT.
引用
收藏
页码:561 / 569
页数:9
相关论文
共 50 条
  • [31] ApoB/ApoA1 ratio and non-HDL-cholesterol/HDL-cholesterol ratio are associated to metabolic syndrome in patients with type 2 diabetes mellitus subjects and to ischemic cardiomyopathy in diabetic women
    Lizet Reynoso-Villalpando, Gabriela
    Sevillano-Collantes, Cristina
    Valle, Yeminia
    Moreno-Ruiz, Inmaculada
    Ramon Padilla-Gutierrez, Jorge
    Javier del Canizo-Gomez, Francisco
    [J]. ENDOCRINOLOGIA DIABETES Y NUTRICION, 2019, 66 (08): : 502 - 511
  • [32] Comparative evaluation of LDL-CT, non-HDL/HDL ratio, and ApoB/ApoA1 in assessing CHD risk among patients with type 2 diabetes mellitus
    Paunica, Ioana
    Mihai, Andrada Doina
    Stefan, Simona
    Pantea-Stoiana, Anca
    Serafinceanu, Cristian
    [J]. JOURNAL OF DIABETES AND ITS COMPLICATIONS, 2023, 37 (12)
  • [33] Effects of concurrent aerobic and resistance training on vascular health in type 2 diabetes: a systematic review and meta-analysis
    Chen, Shengju
    Zhou, Kaixiang
    Shang, Huayu
    Du, Mingyang
    Wu, Linfeng
    Chen, Yu
    [J]. FRONTIERS IN ENDOCRINOLOGY, 2023, 14
  • [34] Plasma homocysteine, Lp(a), and oxidative stress markers in peripheral macroangiopathy in patients with type 2 diabetes mellitus
    Real, Jose T.
    Folgado, Jose
    Molina Mendez, Mercedes
    Martinez-Hervas, Sergio
    Peiro, Marta
    Ascaso, Juan F.
    [J]. CLINICA E INVESTIGACION EN ARTERIOSCLEROSIS, 2016, 28 (04): : 188 - 194
  • [35] Effects of sprint interval or combined aerobic and resistance training on myokines in overweight women with type 2 diabetes: A randomized controlled trial
    Banitalebi, Ebrahim
    Kazemi, AbdolReza
    Faramarzi, Mohammad
    Nasiri, Samira
    Haghighi, Marjan Mosalman
    [J]. LIFE SCIENCES, 2019, 217 : 101 - 109
  • [36] Short term effects of periodontal therapy on inflammatory markers in patients with type-2 diabetes
    Kara, Goze
    Cifcibasi, Emine
    Karsidag, Kubilay
    Cintan, Serdar
    [J]. SAUDI MEDICAL JOURNAL, 2015, 36 (04) : 469 - 476
  • [37] Impact of interval walking training managed through smart mobile devices on albuminuria and leptin/adiponectin ratio in patients with type 2 diabetes
    Sokolovska, Jelizaveta
    Ostrovska, Karina
    Pahirko, Leonora
    Varblane, Gunita
    Krilatiha, Ksenija
    Cirulnieks, Austris
    Folkmane, Inese
    Pirags, Valdis
    Valeinis, Janis
    Klavina, Aija
    Selavo, Leo
    [J]. PHYSIOLOGICAL REPORTS, 2020, 8 (13):
  • [38] Management of Type 2 Diabetes Mellitus: Resistance Training Effects
    Grabert, Derek
    Feito, Yuri
    [J]. STRENGTH AND CONDITIONING JOURNAL, 2013, 35 (06) : 15 - 19
  • [39] Effects of a 12-week moderate-intensity exercise training on blood glucose response in patients with type 2 diabetes A prospective longitudinal study
    Chiang, Shang-Lin
    Heitkemper, Margaret McLean
    Hung, Yi-Jen
    Tzeng, Wen-Chii
    Lee, Meei-Shyuan
    Lin, Chia-Huei
    [J]. MEDICINE, 2019, 98 (36)
  • [40] The Efficacy of Short-Term Toe Resistance Training in Chronic Hemodialysis Patients with Type 2 Diabetes
    Kataoka, Hiroaki
    Miyatake, Nobuyuki
    Matsuda, Naoko
    Hikasa, Yasuaki
    Kitayama, Naomi
    Nagai, Shion
    Tanaka, Satoshi
    [J]. HEALTHCARE, 2023, 11 (01)